Table 3 Characteristics of immunized patients
sJIA (n = 81) | AOSD (n = 18) | |
|---|---|---|
Which immunization* | ||
Pfizer/BioNTech | 72 (88%) | 14 (78%) |
Moderna | 10 (12%) | 8 (44%) |
Oxford/Astra Zeneca | 1 (1%) | 5 (28%) |
Janssen (Johnson & Johnson) | 2 (2%) | 1 (6%) |
Not sure | 1 (1%) | 0 (0%) |
Did not answer | 1 (1%) | 0 (0%) |
Disease activity level at the time of immunization | ||
Inactive Disease | 42 (52%) | 9 (50%) |
Active Disease | 31 (38%) | 6 (33%) |
Immunization before diagnosis | 2 (2%) | 3 (17%) |
Other | 5 (6%) | 0 (0%) |
Did not answer | 1 (1%) | 0 (0%) |
How many doses of COVID-19 immunization | ||
1 dose | 3 (4%) | 0 (0%) |
2 doses | 38 (47%) | 2 (11%) |
3 doses | 32 (40%) | 6 (33%) |
4 doses | 7 (9%) | 10 (56%) |
Did not answer | 1 (1%) | 0 (0%) |
Immunization side effects | ||
Yes | 28 (34%) | 11 (61%) |
No | 52 (64%) | 7 (39%) |
Did not answer | 1 (1%) | 0 (0%) |